Table 1.
Patient data
| FO pre ≤ 2.5 L (L group) | FO pre > 2.5 L (H group) | P | |
|---|---|---|---|
|
N |
31 |
38 |
|
|
FO [L] |
1.1 (0.55, 1.6) |
3.4 (2.8, 4.4) |
<0.001 |
|
FO/ECW% |
7.0 (3.6, 9.3) |
17.7 (15.7, 25.3) |
<0.001 |
|
Diabetes |
11 |
8 |
0.2 |
|
Age [years] |
65 (50,75) |
69 (60, 75) |
0.2 |
|
Gender [m/f] |
18/13 |
27/11 |
0.3 |
|
Dialysis vintage [years] |
4 (2, 7) |
7 (5, 11) |
0.02 |
|
Patients with residual renal function |
0 |
1 |
0.9 |
|
Treatment time [min] |
236 (233, 241) |
237 (234, 241) |
0.5 |
|
UFR [L/hr] |
0.67 (0.47, 0.84) |
0.81 (0.56, 0.9) |
0.2 |
|
UFR [ml/kg BW/h] |
9.5 (5.9, 10.9) |
10.9 (8.0, 13.6) |
0.1 |
|
Dry body weight [kg] |
74.2 (61.6, 78.6) |
68.4 (61.0, 74.5) |
0.2 |
|
BMI |
26.4 (23.5, 28.8) |
24.3 (21.6, 26.7) |
0.2 |
|
Treatment modality [HDF-OL/HD/HFD/HF] |
3/26/2/0 |
6/27/3/2 |
0.6 |
|
HD related episodes (cramps, dizziness, hypotension) |
5 |
6 |
0.9 |
|
Left ventricular hypertrophy |
21 |
25 |
0.9 |
|
Peripheral vascular disease |
17 |
12 |
0.8 |
|
Coronary heart disease |
10 |
11 |
0.2 |
|
Hypertension |
31 |
36 |
0.5 |
|
β-blockers |
10 |
14 |
0.8 |
|
ACE inhibitors |
9 |
11 |
0.8 |
| Calcium antagonist | 14 | 16 | 0.9 |
The values are expressed as median (25°, 75° percentiles) or numbers of patients.
HDF-OL: Hemodiafiltration OnLine; HD:Hemodialysis; HFD: High Flux Dialysis; HF: Hemofiltration.
Significant differences are indicated in bold.